Mammalian brain consumption by blood donors in the United States: Brains today, deferred tomorrow?

Transfusion

Volumn 44, Issue 5, 2004, Pages 667-674

  Schreiber, George B ^a   Sanchez, Ana M ^b   Garratty, George ^b   Nass, Catharie C ^b   Tu, Yongling ^b   Busch, Michael P ^b  

^a WESTAT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ASIAN AMERICAN; BLOOD DONOR; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN; CATTLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; FEMALE; FOOD INTAKE; HEALTH CARE POLICY; HEALTH CENTER; HISPANIC; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MAMMAL; REVIEW; SWINE; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANIMALS; BLOOD DONORS; BRAIN; CATTLE; CREUTZFELDT-JAKOB SYNDROME; DIET; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 2342551483     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03114.x     Document Type: Review

References (50)

1. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
2. Collinge J, Sidle KC, Meads J, et al. Molecular analysis of prion strain variation and the etiology of "new variant" CJD. Nature 1996;383:685-90.
3. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 1997;389:498-501.
4. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997;389:448-50, 526.
5. Scott MR, Will R, Ironside J, et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A 1999;96:15137-42.
6. Andrews NJ. Incidence of variant Creutzfeldt-Jacob disease onsets and deaths in the UK. January, 1994-September, 2003 (updated October 21, 2003). www.cjd.edsac.uk.
7. Centers for Disease Control and Prevention. New variant CJD fact sheet (updated May 21, 2003). http://www.cdc.gov.
8. Holmes K. First Canadian dies of human mad cow strain. Reuters. August 8, 2002.
9. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-9.
10. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-80.
11. Houston F, Foster JD, Chong A, et al. Transmission of BSE by blood transfusion in Sheep. Lancet 2000;356:999-1000.
12. Taylor DM, Ferie K, Reichl HE, Somerville RA. Infectivity in the blood of mice with a BSE-derived agent. J Hospital Infect 2000;46:78-9.
13. Bons N, Lehmann S, Mestre-Frances N, et al. Brain and buffy coat transmission of bovine spongiform encephalopathy (BSE) to the primate Microcebus murinus. Transfusion 2002;42:513-6.
14. Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen. Virol 2002;83:2897-905.
15. U.K. Department of Health. Government accepts advice on leucodepletion from Spongiform Encephalopathy Advisory Committee. Press Release, July 17, 1998.
16. New Zealand Ministry of Health. Measures in place to protect blood supplies. Press Release, November 18, 1999.
17. World Health Organization. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion. Weekly Epidemiol Record 2000;75:377-9.
18. Dobson R. Scientists show that vCJD can be transmitted through blood. BMJ 2000;321:721.
19. US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products. Rockville, MD: USFDA, January, 2002. http://www.fda.gov/cber/guidelines.htm.
20. Transmissible Spongiform Encephalopathies Advisory Committee. Gaithersburg, MD, June 26-27, 2002. http://www.fda.gov/ohrms/dockets/ac/02/transcripts/3868T2.
21. Dodd RY, Busch MP. Animal models of bovine spongiform encephalopathy and vCJD infectivity in blood: two swallows do not a summer make. Transfusion 2002;42:509-12.
22. Brown P. Variant CJD transmission through blood: risks to predictors and "predictees." Transfusion 2003;43:425-7.
23. Kurland J. The heart of the precautionary principle in democracy. Public Health Reports 2002;117:498-500.
24. Tickner JA. Precaution and preventive public health policy. Public Health Reports 2002;117:493-7.
25. Stoto MA. The precautionary principle and emerging biological risks: lessons from swine flu and HIV in blood products. Public Health Reports 2002;117:546-52.
26. Wilson K, Wilson M, Hebert PC, Graham I. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy. Transfusion Med Rev 2003;17:89-94.
27. Zuck TF, Thomson RA, Schreiber GB, et al. The retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995;35:944-51.
28. Glynn SA, Smith JW, Schreiber GB, et al. Repeat whole-blood and plateletpheresis donors: unreported deferrable risks, reactive screening tests, and response to incentive programs. Transfusion 2001;41:736-43.
29. Sharma UK, Schreiber GB, Glynn SA, et al. Knowledge of HIV/AIDS transmission and screening in United States blood donors. Transfusion 2001;41:1341-50.
30. Wesvar PC version 4. Rockville, MD: Westat, 2000.
31. SAS version 8.0. Cary, NC: SAS Institute, 1999.
32. The National CJD Surveillance Unit, Western General Hospital and the Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine. Creutzfeldt-Jakob disease surveillance in the UK: Eleventh Annual Report, 2002. www.cjd.edsac.uk
33. Lewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
34. BBC. Patients to be told of vCJD Risk. BBC News, January 29, 2002.
35. Woodcock A. CJD blood transfusion risk. British Press Association, August 2, 2002.
36. Proceedings: Joint WHO/FAO/OIE Technical Consultation on BSE. Public health, animal health and trade. Paris: OIE, June 11-14, 2001.
37. Office International des Epizooties World Organization for Animal Health. Number of reported cases of bovine spongiform encephalopathy (BSE) (updated June 13, 2003). http://www.oie.int.
38. World Health Organization. The revision of the surveillance case definition for variant Creutzfeldt-Jakob disease (vCJD). Report of a WHO consultation. Edinburgh, UK, May 17, 2001. http://www.who.int/emc.
39. Food Standards Agency (U.K.). BSE and sheep: report of the core stakeholder group. May, 2002. http://www.food.gov.uk.
40. Imrie R. Deaths of three men probed for link to Wisconsin deer disease. Associated Press, August 1, 2002.
41. European Commission Scientific Steering Committee Preliminary Opinion on Oral Exposure of Humans to the BSE agent. Infective Dose and Species Barrier. Opinion adopted March, 2000.
42. European Commission Scientific Steering Committee. Opinion on the human exposure risk (HER) via food with respect to BSE. Opinion adopted December, 1999.
43. World Health Organization. Emerging and other communicable diseases (EMC): bovine spongiform encephalopathy (BSE) fact sheet. Fact Sheet N113. March, 1996.
44. Bryant G, Monk P. Final report of the investigation into the North Leicestershire cluster of variant Creutzfeldt-Jakob. Report presented to the Leicestershire Health Authority, April 4, 2001.
45. Schreiber GB, McCurdy P, Sanchez AM, et al. Frequency of blood donation and reserve capacity of the blood supply (abstract). Transfusion 1999;39:32S.
46. Wilesmith JW, Ryan JB, Atkinson MJ. Bovine spongiform encephalopathy: epidemiological studies on the origin. Vet Rec 1991;128:199-203.
47. Cohen B, Erickson P, Powell A. The impact of length of recall period on the estimation of health events. Alexandria: American Statistical Association, Proceedings of the Social Statistics Section, 1983:497-502.
48. Gomoll J. Understanding chronic wasting disease in Wisconsin: the first step to disease control. Madison: Wisconsin Department of Natural Resources, PUB-WM-399, 2002. http://www.dnr.state.wi.us/org/land/wildlife/whealth/issues/cwd/cwdbook.pdf.
49. Center for Animal Health and Food Safety. Key information about chronic wasting disease (CWD). Duluth: University of Minnesota, March, 2002. http://www.cvm.umn.edu/anhlth_foodsafety/chronic_wasting_disease. pdf.
50. Idaho Department of Fish and Game. Hunters' guide to chronic wasting disease. September, 2002. www2.state.id.us/fishgame/hunt/programsinfo/cwd/cwd.pdf.